PCV52 PRESCRIBING AND EXPENDITURES FOR PCSK9 INHIBITORS IN...

PCV52 PRESCRIBING AND EXPENDITURES FOR PCSK9 INHIBITORS IN THE MEDICARE PART D POPULATION IN 2016

Borrelli, E., Kogut, S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.488
Date:
May, 2019
File:
PDF, 381 KB
2019
Conversion to is in progress
Conversion to is failed